These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


399 related items for PubMed ID: 16849621

  • 21. Preventive and therapeutic HPV vaccines.
    Monie A, Hung CF, Wu TC.
    Curr Opin Investig Drugs; 2007 Dec; 8(12):1038-50. PubMed ID: 18058574
    [Abstract] [Full Text] [Related]

  • 22. The GARDASIL vaccine can prevent cervical carcinoma caused by human papilloma virus (HPV) (results from our participation and from the study carried out in Greece).
    Ansstasiou-Fotaki P, Deligeoroglou E, Kreatsas G.
    Akush Ginekol (Sofiia); 2007 Dec; 46(3):17-20. PubMed ID: 18018777
    [Abstract] [Full Text] [Related]

  • 23. Introducing human papillomavirus vaccines - questions remain.
    Paavonen J, Lehtinen M.
    Ann Med; 2008 Dec; 40(3):162-6. PubMed ID: 18382882
    [Abstract] [Full Text] [Related]

  • 24. Human papillomavirus vaccine and cervical cancer prevention: practice and policy implications for pharmacists.
    McIntosh J, Sturpe DA, Khanna N.
    J Am Pharm Assoc (2003); 2008 Dec; 48(1):e1-13; quiz e14-7. PubMed ID: 18192123
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Integrating human papillomavirus vaccination in cervical cancer control programmes.
    Franco EL, Coutlée F, Ferenczy A.
    Public Health Genomics; 2009 Dec; 12(5-6):352-61. PubMed ID: 19684447
    [Abstract] [Full Text] [Related]

  • 29. Vaccines for the prevention of human papillomavirus and associated gynecologic diseases: a review.
    Ault KA.
    Obstet Gynecol Surv; 2006 Jun; 61(6 Suppl 1):S26-31. PubMed ID: 16729901
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Human papillomavirus vaccines in development: if they're successful in clinical trials, how will they be implemented?
    Shaw AR.
    Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S246-8. PubMed ID: 16213009
    [Abstract] [Full Text] [Related]

  • 33. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP).
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2010 May 28; 59(20):630-2. PubMed ID: 20508594
    [Abstract] [Full Text] [Related]

  • 34. [Prophylactic and therapeutic vaccination against human papillomavirus].
    Brun JL, Riethmuller D.
    J Gynecol Obstet Biol Reprod (Paris); 2007 Nov 28; 36(7):631-41. PubMed ID: 17822860
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Human papillomavirus vaccine for genotypes 6, 11, 16 and 18: new drug. Cervical cancer prevention: high hopes...
    Prescrire Int; 2007 Jun 28; 16(89):91-4. PubMed ID: 17582921
    [Abstract] [Full Text] [Related]

  • 37. GARDASIL: prophylactic human papillomavirus vaccine development--from bench top to bed-side.
    Shi L, Sings HL, Bryan JT, Wang B, Wang Y, Mach H, Kosinski M, Washabaugh MW, Sitrin R, Barr E.
    Clin Pharmacol Ther; 2007 Feb 28; 81(2):259-64. PubMed ID: 17259949
    [Abstract] [Full Text] [Related]

  • 38. Measuring serum antibody to human papillomavirus following infection or vaccination.
    Frazer IH.
    Gynecol Oncol; 2010 Jun 28; 118(1 Suppl):S8-11. PubMed ID: 20494221
    [Abstract] [Full Text] [Related]

  • 39. Prospects and prejudices of human papillomavirus vaccines in India.
    Das BC, Hussain S, Nasare V, Bharadwaj M.
    Vaccine; 2008 May 23; 26(22):2669-79. PubMed ID: 18455843
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 20.